add items to your
binder to email or
print all at once
Items In Binder
Site Lawyers
Sobi's Acquisition of Dova

On September 30, 2019, Swedish Orphan Biovitrum AB (publ) (“Sobi”), an international biopharmaceutical company that provides access to innovative therapies for people affected by rare diseases, announced a definitive agreement to acquire Dova Pharmaceuticals, Inc. (“Dova”), maker of Doptelet, used for the treatment of thrombocytopenia. The transaction is valued at up $915 million on a fully diluted basis. Cravath is representing Sobi in connection with the transaction.

The Cravath team is led by partner Damien R. Zoubek and includes senior attorney Brittain A. Rogers and associates Jin‑Kyu Baek, Nathan H. Trunnell, Michael P. E. Dooley and Ashkan Towhid on M&A matters; partner Kara L. Mungovan and associate Andrew T. Davis on tax matters; partner Eric W. Hilfers, senior attorney Nicole F. Foster and associates Jana I. Hymowitz and Brendon J. Rivard on executive compensation and benefits matters; partner David J. Kappos, specialist attorney Anthony N. Magistrale and associate Carys A. Johnson on intellectual property matters; partner Matthew Morreale on environmental matters; of counsel Christopher J. Kelly on financing matters; and senior attorney Jesse M. Weiss on antitrust matters.